Saturday - March 14, 2026
Michigan Medicine: FDA-approved Cancer Drug Fedratinib Reshapes How Cell Organelles Communicate, Providing Therapeutic Avenues
March 14, 2026
ANN ARBOR, Michigan, March 14 (TNSjou) -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release:

* * *

FDA-approved cancer drug fedratinib reshapes how cell organelles communicate, providing new therapeutic avenues

The anti-cancer drug alters communication between organelles that control specific metabolic pathways

*

Cells behave like cities and organelles carry out infrastr . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products